Ascentage Pharma Group International American Depository Shares (AAPG)

Price$17.20

Value ScoreD

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-50.37%

Price vs S&P 500 (4W)-18.33%

VGM Score44.48

Market Capitalization$1.96B

All Metrics

Book Value / Share (Quarterly)$0.52

P/TBV (Annual)13.14x

Revenue Growth (3Y)39.89%

Cash Flow / Share (Quarterly)$-0.47

Price vs S&P 500 (YTD)-40.32%

Gross Margin (TTM)91.48%

Net Profit Margin (TTM)-216.47%

EPS (TTM)$-0.51

10-Day Avg Trading Volume2.93M

EPS Excl Extra (TTM)$-0.51

Revenue Growth (5Y)115.16%

EPS (Annual)$-0.51

ROI (Annual)-37.61%

Gross Margin (Annual)91.48%

Net Profit Margin (5Y Avg)-779.84%

Cash / Share (Quarterly)$0.97

Revenue Growth QoQ (YoY)116.96%

ROA (Last FY)-31.35%

Revenue Growth TTM (YoY)-41.46%

EBITD / Share (TTM)$-0.46

ROE (5Y Avg)-411.76%

Operating Margin (TTM)-205.93%

Cash Flow / Share (Annual)$-0.47

P/B Ratio8.70x

P/B Ratio (Quarterly)12.49x

Net Income / Employee (Annual)$-238,573

EV / Revenue (TTM)19.21x

Net Interest Coverage (TTM)-17.79x

ROA (TTM)-35.46%

EPS Incl Extra (Annual)$-0.51

Current Ratio (Annual)1.79x

Quick Ratio (Quarterly)1.66x

3-Month Avg Trading Volume2.27M

52-Week Price Return46.39%

Revenue / Employee (TTM)$110,209

Tangible BV / Share (Quarterly)$0.50

P/S Ratio (Annual)20.07x

Asset Turnover (Annual)0.14x

52-Week High$95.35

Operating Margin (5Y Avg)-787.36%

EPS Excl Extra (Annual)$-0.51

CapEx CAGR (5Y)-35.73%

Tangible BV CAGR (5Y)8.99%

26-Week Price Return-42.45%

Quick Ratio (Annual)1.69x

13-Week Price Return-22.66%

Total Debt / Equity (Annual)1.49x

Current Ratio (Quarterly)1.79x

Enterprise Value$1.62B

Revenue / Share Growth (5Y)94.64%

Asset Turnover (TTM)0.16x

Book Value / Share Growth (5Y)-1.08%

Revenue / Employee (Annual)$110,209

Inventory Turnover (Annual)2.78x

Pretax Margin (Annual)-215.29%

Cash / Share (Annual)$0.97

3-Month Return Std Dev60.05%

Gross Margin (5Y Avg)90.47%

Net Income / Employee (TTM)$-238,573

ROE (Last FY)-93.83%

Net Interest Coverage (Annual)-8.16x

EPS Basic Excl Extra (Annual)$-0.51

Receivables Turnover (TTM)3.42x

Total Debt / Equity (Quarterly)1.49x

EPS Incl Extra (TTM)$-0.51

Receivables Turnover (Annual)3.42x

ROI (TTM)-43.71%

P/S Ratio (TTM)20.07x

Pretax Margin (5Y Avg)-816.16%

Revenue / Share (Annual)$0.24

Tangible BV / Share (Annual)$0.50

Price vs S&P 500 (52W)45.75%

Year-to-Date Return-33.36%

5-Day Price Return-7.29%

EPS Normalized (Annual)$-0.51

ROA (5Y Avg)-28.33%

Net Profit Margin (Annual)-216.47%

Month-to-Date Return-11.26%

Cash Flow / Share (TTM)$-0.48

EBITD / Share (Annual)$-0.46

Operating Margin (Annual)-205.93%

LT Debt / Equity (Annual)0.56x

ROI (5Y Avg)-36.46%

LT Debt / Equity (Quarterly)0.56x

EPS Basic Excl Extra (TTM)$-0.51

P/TBV (Quarterly)13.14x

P/B Ratio (Annual)12.49x

Inventory Turnover (TTM)2.78x

Pretax Margin (TTM)-215.29%

Book Value / Share (Annual)$0.52

Price vs S&P 500 (13W)-30.91%

Beta0.77x

Revenue / Share (TTM)$0.23

ROE (TTM)-124.87%

52-Week Low$34.52

vGradeD

gGradeB

mGradeC

vgmGradeC

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.31

4.36

4.33

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
AAPGAscentage Pharma Group International American Depository Shares	D	B	C	$17.20
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Ascentage Pharma is a clinical-stage biotechnology company developing novel small-molecule therapies for cancers, hepatitis B, and age-related diseases. The company's platform uses protein-protein interaction inhibitors to restore cancer cell apoptosis, with primary focus on hematological malignancies. Operations span the United States and China.